Definitive Healthcare Q3 revenue $57.4M (+33% YoY); net loss narrows; appoints Jon Maack as President

Definitive Healthcare Corp.

2022-Q3 EPS reported -$0.16 revenue$162,054,000

Revenue $57.4M (+33% YoY), net loss $6.4M vs $21.0M; adjusted EBITDA $16.4M (29% revenue).
Q4 revenue guidance $58-59M (median +26% YoY); full-year 2022 revenue guidance $220-221M.
Jon Maack appointed President, effective Nov 3, 2022; reports to CEO; oversees product, engineering, strategy, M&A.
Maack received $400k base salary, 70% bonus target, 546k RSUs; previously Chief Strategy Officer at athenahealth.
Unlevered free cash flow $15.5M (27% revenue) in Q3; trailing twelve-month $67.4M (32% revenue).

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jonathan Maack

President

DH · Definitive Healthcare Corp.

Effective: 2022-11-03
Filed: November 3, 2022, 7:59 PM ET

On November 3, 2022, the Company announced that, on September 16, 2022, its Board of Directors (the "Board") appointed Jonathan Maack to the position of President, effective November 3, 2022 (the "Effective Date").

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Definitive Healthcare Corp. reported the third quarter ended September 30, 2022 results: revenue $57.4 million, net income ($6.4) million. Guidance raised.

Period: the third quarter ended September 30, 2022
Revenue: $57.4 million
Net income: ($6.4) million
Guidance: raised
Result: reported results

Exact text from the filing

EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2022 Third quarter revenue grew 33% year-over-year to $57.4 million Framingham, MA (November 3, 2022) – Definitive Healthcare Corp. (“Definitive Healthcare" or the "Company") (Nasdaq: DH), an industry leader in healthcare commercial intelligence,

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Definitive Healthcare Corp. reported Full Year 2022 results: revenue in the range of $220 – $221 million, net income expected to be $30 – 31 million, EPS $0.19– $0.20. Guidance raised.

Period: Full Year 2022
Revenue: in the range of $220 – $221 million
Net income: expected to be $30 – 31 million
EPS: $0.19– $0.20
Guidance: raised
Result: guidance update

Exact text from the filing

Revenue is expected to be in the range of $220 – $221 million, an increase of 33% from prior year at the midpoint.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Jonathan Maack was appointed as President at Definitive Healthcare Corp..

Action: appointed
Role: President

Exact text from the filing

On November 3, 2022, the Company announced that, on September 16, 2022, its Board of Directors (the "Board") appointed Jonathan Maack to the position of President, effective November 3, 2022 (the "Effective Date").

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-22-021909

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.